Competitors point out the sheer volume of transactions that Muñiz Ramírez Pérez-Taiman & Olaya is able to handle when talking about Peru's largest firm. The transactional quantity is likely due to their streamlined fee structures and low prices....
[more]
Competitors point out the sheer volume of transactions that Muñiz Ramírez Pérez-Taiman & Olaya is able to handle when talking about Peru's largest firm. The transactional quantity is likely due to their streamlined fee structures and low prices. "[They] have a very low retainer fee," says one competitor. "They can do it because they have a very good organisation. They can handle it."
Mauricio Olaya has built what a competitor calls an "extensive" M&A practice. In January, Olaya advised Inkafarma, a Peruvian drugstore chain with 340 pharmacies, when it was acquired by Interbank for $360 million. He also helped Pesquera Alejandría as it was acquired by China Fisheries in a $30 million deal to create the sixth-largest fishmeal company in Peru. And to round things out, Olaya assisted the Corporación Infamarsa a Peruvian laboratory as it was acquired by Israeli pharmaceutical company, Teva.
In project finance, a team led by partner Sergio Oquendo counselled Gas Natural de Lima y Callao (GNLC) who were granted a $135 million credit facility. The club deal was lent by Corporación Andina de Fomento, International Finance Corporation (IFC), and the ICF Debt Pool to finance GNLC's investment programs, aimed at expanding natural gas distribution. Additionally, the firm helped Transportadora de Gas del Perú (TGP) secure long-term financing from Banco Nacional de Desenvolvimento Econômico e Social (BNDES) for an expansion project in the Peruvian jungle for the Camisea field. This was the first "buyer's credit" given by BNDES to a Peruvian company.
[hide]